Chemotherapy & Immunotherapy – Istituto Clinico Humanitas

Survival:9.3 months
Toxicity Grade:4
Treatments:Chemotherapy
Immunotherapy
Drugs:Adriamycin
Platinol
Country:Italy
City/State/Province:Milano
Hospital:Istituto Clinico Humanitas
Journal:Link
Date:8/2001

 

Description:
Patients: This Phase II study involved 37 patients with malignant pleural mesothelioma who had not received chemotherapy or biological therapy before.

Treatment: The treatment consisted of the chemotherapy drugs cisplatin (platinol) and doxorubicin (adriamycin) with alpha-2b interferon.

Toxicity: Grade 4 toxicities included hematologic and renal.

Results: The median survival was 9.3 months.

Correspondence: Hector Soto Parra

Get your free copy of
“Surviving Mesothelioma” Today!